Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2005
12/22/2005US20050282272 inducing a reduced lymphocyte proliferative response to a Major Histocomatibilty Complex (MHC) type presented on an human embryonic stem (hES) cell in a subject; induces a state of inflammatory quiescence or immune unresponsiveness, which in turn enhances engraftment of the stem cells
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050281904 Kefir extract as an anti-cancer agent
12/22/2005US20050281898 Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/22/2005US20050281895 Slimming cosmetic composition containing a substance inducing the production of IL-6
12/22/2005US20050281839 Spirulina composition and antiallergic food
12/22/2005US20050281797 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd
12/22/2005US20050281796 Targeting damaged lung tissue
12/22/2005US20050281795 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
12/22/2005US20050281793 T cell activation
12/22/2005US20050281790 Mesenchymal precursor cell
12/22/2005US20050281789 Transcutaneous and/or transdermal transport of materials
12/22/2005US20050281788 Compositions comprising muscle progenitor cells and uses thereof
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005US20050281785 Method of reducing side effects of cancer therapy using p53 recombinant adenovirus
12/22/2005US20050281780 Contacting, by ductal cannulation, the ductal epithelium of the exocrine gland with a cytolytic virus to destroy less than all of the ductal epithelium so as to inhibit formation of cancer of ductal epithelial origin
12/22/2005US20050281756 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
12/22/2005DE102004026074A1 Therapeutic influencing of cell and cell structures, useful in the treatment of diseases related with the malfunction of, e.g. cells or organs in humans, comprises exposing the cells to a weak quasi-electrostatic field
12/22/2005DE102004025869A1 Bioprotektivum Bioprotektivum
12/22/2005CA2611377A1 Bacterial compositions for the treatment of cancer
12/22/2005CA2569978A1 Neural stem cells
12/22/2005CA2569556A1 Unique manuka factor (umf) fortified honey
12/22/2005CA2568995E Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005CA2566851A1 Compositions comprising female germline stem cells and methods of use thereof
12/21/2005EP1607483A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use
12/21/2005EP1607108A1 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer
12/21/2005EP1607096A2 Nutraceutical composition containing milk enzymes useful as synbiotic
12/21/2005EP1606997A1 Method of inhibiting freeze concentrating of substance in wet material, method of inhibiting deactivation of physiologically active substance, and process for producing lyophilizate or frozen matter having component homogeneously diffused therein
12/21/2005EP1606411A1 Mutant vesicular stomatitis viruses and use thereof
12/21/2005EP1606396A2 Methods of promoting the differentiation of stem cells
12/21/2005EP1606394A1 Lactic acid utilising bacteria and their therapeutic use
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1605975A1 Composition and method for the treatment and prevention of enteric bacterial infections
12/21/2005EP1605970A2 Anti-cancer virus desensitization method
12/21/2005EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/21/2005EP1605763A2 Newcastle disease virus administration
12/21/2005EP1509087A4 Treatment for diabetes
12/21/2005EP1468075B1 Novel lactobacillus sp. strain and use thereof
12/21/2005EP1250161B1 Polymer blends as biodegradable matrices for preparing biocomposites
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1119581B1 USE OF A VECTOR EXPRESSING RB2/p130 FOR PREVENTION OR TREATMENT OF RESTENOSIS OR ATHEROSCLEROTIC PLAQUES
12/21/2005EP0906415A4 Regeneration and augmentation of bone using mesenchymal stem cells
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1709409A Anti-tumor agent, beverages and foods using the same, and a process for manufacturing the anti-tumor agent
12/21/2005CN1709284A Extraction of anti-tumour active ingredient fatty acid from ground beetle
12/21/2005CN1709283A Oleanolic acid phospholipid compound and its preparing method
12/21/2005CN1709282A L-amino acid water-soluble pearl powder and its preparing method
12/21/2005CN1232265C Liquid for moist of eyes and its preparation method
12/21/2005CN1232264C Technology for producing sheep placenta biological preparations using superlow-temperature ultrasonic high-pressure egg albumen cracking method
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977084 Pet food containing Perna canaliculus for maintenance of joint health and alleviation of arthritic symptoms
12/20/2005US6977073 Method for stimulating an immune response
12/15/2005WO2005118825A2 Chimeric adenoviruses for use in cancer treatment
12/15/2005WO2005118789A2 Therapeutic delivery of adenosine into a tissue
12/15/2005WO2005118014A2 Decellurisation processes for making bioprotheses
12/15/2005WO2005117926A1 Agent for intestinal bacterial flora amelioration
12/15/2005WO2005117923A1 Bioprotective
12/15/2005WO2005117921A1 Oral form of administration containing probiotic bacteria
12/15/2005WO2005117532A2 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005WO2005077093A3 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
12/15/2005WO2005072764A3 Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005WO2005065269A3 Compositions and method for decreasing the appearance of skin wrinkles
12/15/2005WO2005021706A3 Delivery of compounds with rehydrated blood cells
12/15/2005WO2005007832A3 System for external control of oncolytic virus replication
12/15/2005WO2003029432A3 Human mesenchymal progenitor cell
12/15/2005US20050277603 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/15/2005US20050277578 Immunity generation
12/15/2005US20050277190 Progenitor cells; differentiation; cloning
12/15/2005US20050277112 Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
12/15/2005US20050277108 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
12/15/2005US20050276864 Cellular therapy to heal vascular tissue
12/15/2005US20050276861 Ex-vivo application of solid microparticulate therapeutic agents
12/15/2005US20050276788 Self-containing lactobacillus strain
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005DE202005015885U1 Pharmaceutical form of medicated moorland water as sweet or spicy dry extrudates, useful for increasing the well being of stomach or intestine tract, comprises grain, spicy mixture and/or flavors
12/15/2005DE102004026706A1 Orale Darreichungsform enthaltend probiotische Bakterien The oral dosage form containing probiotic bacteria
12/15/2005DE10128980B4 Gen-modifizierte alloreaktive T-Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung Gene-modified alloreactive T-cells, processes for their preparation and their use
12/15/2005CA2836987A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2709865A1 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005CA2568171A1 Oral administration form comprising probiotic bacteria
12/15/2005CA2567094A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2560472A1 Method for improved breast milk feeding to reduce the risk of allergy
12/14/2005EP1605053A1 Use of adenoviruses mutated in the VA genes for cancer treatment
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1605039A1 Dendritic cell presenting alpha-glycosylceramide derivative and a ntigen and usable in suppressing immune response
12/14/2005EP1605038A1 Method of cell culturing and cell sheet
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604018A1 Cartilaginous cell culture medium and the use thereof
12/14/2005EP1604017A2 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof
12/14/2005EP1604009A2 Method for identifying risk of melanoma and treatments thereof
12/14/2005EP1603951A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies
12/14/2005EP1603594A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof
12/14/2005EP1603405A2 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus
12/14/2005EP1599715A3 Autologous or homologous coagulant produced from anticoagulated whole blood
12/14/2005EP1439847A4 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
12/14/2005EP1438410B1 Promoters to control cell differentiation
12/14/2005EP1416944B1 Composition for treatment of articular cartilage damage
1 ... 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 ... 1259